doi:10.3969/j.issn.1673-8640.2019.06.022

Abstract

CLC Number:

R446.1

. [J]. Laboratory Medicine, 2019, 34(6): 571-572.

Figures/Tables 1

References 7

[1]	CHEN J H,DESHPANDE V.IgG4-related disease and the liver[J]. Gastroenterol Clin North Am,2017,46(2):195-216.
[2]	ESPARVARINHA M,NICKHO H,MOHAMMADI H,et al.The role of free kappa and lambda light chains in the pathogenesis and treatment of inflammatory diseases[J]. Biomed Pharmacother,2017,91:632-644.
[3]	PRIETO J,MELERO I,SANGRO B.Immunological landscape and immunotherapy of hepatocellular carcinoma[J]. Nat Rev Gastroenterol Hepatol,2015,12(12):681-700.
[4]	KRENKEL O,TACKE F.Liver macrophages in tissue homeostasis and disease[J]. Nat Rev Immunol,2017,17(5):306-321.
[5]	SCHMILOVITZ-WEISS H,COHEN M,PAPPO O,et a1. Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post-transplant hepatitis C infection[J]. Clin Transplant, 2007,21(3):391-397.
[6]	WU K,KRYCZEK I,CHEN L,et al.Kupffer cell suppression of CD8+ T cells in human hepatocellular carcinoma is mediated by B7-H1/programmed death-1 interactions[J]. Cancer Res,2009,69(20):8067-8075.
[7]	ZHANG Q,LOU Y,BAI XL,et al.Immunometabolism:a novel perspective of liver cancer microenvironment and its influence on tumor progression[J]. World J Gastroenterol,2018, 24(31):3500-3512.

组别	例数	IgG（g/L）	IgA（g/L）	IgM（g/L）	κ轻链（g/L）	λ轻链（g/L）	κ/λ比值
急性肝炎组	33	12.66±2.00	1.85±0.48	2.88±0.96*	2.65±0.80	1.57±0.52	1.90±0.88
慢性肝炎组	41	24.12±3.98*#	3.60±0.93*#	1.57±0.66#	4.83±1.20*#	2.57±0.79*#	2.01±0.70
肝硬化组	38	21.95±4.10*#	4.10±1.10*#	1.39±0.50#	5.27±1.03*#	2.81±0.69*#	1.91±0.26
正常对照组	55	11.69±1.19	1.91±0.54	1.33±0.40	2.71±0.84	1.49±0.59	2.03±0.73

组别	例数	IgG（g/L）	IgA（g/L）	IgM（g/L）	κ轻链（g/L）	λ轻链（g/L）	κ/λ比值
急性肝炎组	33	12.66±2.00	1.85±0.48	2.88±0.96*	2.65±0.80	1.57±0.52	1.90±0.88
慢性肝炎组	41	24.12±3.98*#	3.60±0.93*#	1.57±0.66#	4.83±1.20*#	2.57±0.79*#	2.01±0.70
肝硬化组	38	21.95±4.10*#	4.10±1.10*#	1.39±0.50#	5.27±1.03*#	2.81±0.69*#	1.91±0.26
正常对照组	55	11.69±1.19	1.91±0.54	1.33±0.40	2.71±0.84	1.49±0.59	2.03±0.73

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 1

References 7

Related Articles 15

Recommended Articles

Metrics